2025年8月，临汾爱尔眼科医院手术室内，一场关乎光明的手术正在紧张进行。随着推注器缓缓将晶体植入患者眼内，由太原爱尔眼科医院院长高岩主刀的飞秒激光辅助白内障超声乳化抽吸+全国首批臻无极TECNIS PureSee™ ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Patients who received the Tecnis PureSee extended depth of focus IOL had a high tolerance to residual refractive error, ...

Johnson & Johnson (JNJ) is back in the spotlight after presenting extensive clinical and real world data for its recently FDA ...

The TECNIS PureSee™ IOL, recently FDA-approved and recognized with the 2025 MedTech Breakthrough Award for “Best New Technology Solution – Ophthalmology,” is the first and only FDA-approved EDOF IOL ...

Johnson & Johnson (NYSE: JNJ) will present data from two major studies supporting the performance of its recently FDA-approved TECNIS PureSee intraocular lens (IOL) at the 2026 American Society of ...

Find your next quality investment with Simply Wall St's easy and powerful screener, trusted by over 7 million individual investors worldwide. Johnson & Johnson (NYSE:JNJ) received FDA approval for its ...

Please provide your email address to receive an email when new articles are posted on . BARCELONA, Spain — In this Healio Video Perspective from the European Society of Cataract and Refractive ...

Johnson & Johnson (NYSE: JNJ) announced U.S. Food and Drug Administration (FDA) approval of TECNIS PureSee IOL, an extended depth of focus (EDOF) intraocular lens (IOL) intended for use in cataract ...

AUSTIN, TX, UNITED STATES, April 2, 2026 /EINPresswire.com/ — Dell Laser Consultants is proud to be among the first practices in the United States to offer the ...

Johnson & Johnson (NYSE: JNJ) announced U.S. Food and Drug Administration (FDA) approval of TECNIS PureSee IOL, an extended depth of focus (EDOF) intraocular lens (IOL) intended for use in cataract ...